Signal Transduction Flashcards

1
Q

What are signalling networks?

A

Signalling networks involve signals on the outside of a cell being sensed by receptor tyrosine kinases or other proteins through the binding of growth factors or ligands.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What happens when a growth factor binds to a receptor?

A

It causes a conformational intracellular change in the receptor, setting off an intracellular signalling cascade that affects transcription factors and gene expression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are growth factors?

A

Polypeptides that are primary mediators of intracellular communication, released from cells or organs to direct cells to act in a particular way.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are hormones?

A

Hormones act at a distance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are paracrine factors?

A

Paracrine factors act locally.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are juxtacrine factors?

A

Juxtacrine factors act through cell-cell contact.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are autocrine factors?

A

Autocrine factors act on the same cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are intracrine factors?

A

Intracrine factors act intracellularly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are growth factor receptors?

A

They can be normal type/wild type or have oncogenic mutations that induce activation in a ligand-independent manner.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the effect of oncogenic mutations in growth factor receptors?

A

They can cause inappropriate activation of downstream proteins or transcription factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is phosphorylation?

A

The transfer of a high-energy phosphate group from ATP or GTP to a protein, catalyzed by kinases, altering the protein’s conformation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What initiates the intracellular signalling cascade?

A

Ligand binding to the extracellular ligand binding domain causes receptor dimerization and autophosphorylation, activating the intracellular tyrosine kinase domain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the role of PKC in the phosphatidylinositol pathway?

A

PKC acts downstream as a node in multiple pathways regulating cancer and stem cell phenotypes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does AKT do?

A

AKT promotes survival, proliferation, and cell growth by phosphorylating various substrates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of mTOR?

A

mTOR is a key node in metabolism, regulating protein synthesis and allowing cell size increase and division.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the RAS pathway?

A

A signalling pathway that begins with the binding of a growth factor to a growth factor receptor, activating RAS.

17
Q

What are GEFs and GAPs in relation to RAS?

A

GEFs promote the active state of RAS, while GAPs promote the inactive state by hydrolyzing GTP to GDP.

18
Q

What are the three types of oncogenes related to RAS?

A

h-ras, k-ras, and n-ras, which can cause sarcomas and are frequently mutated in various cancers.

19
Q

What is the significance of HER2 in cancer?

A

HER2 can form homodimers or heterodimers and is overexpressed in several cancers, leading to poor survival outcomes.

20
Q

What is Herceptin (Trastuzumab)?

A

A humanized monoclonal antibody that targets HER2, preventing it from forming homodimers.

21
Q

What are the pleiotropic effects of growth factor receptors?

A

They can cause multiple phenotypic effects from the activation of a single growth factor receptor.

22
Q

What is IRESSA?

A

A drug that targets the tyrosine kinase activity of EGFR.

23
Q

What is Lapatinib?

A

An orally active and reversible RTK inhibitor that targets the tyrosine kinase activity of EGFR and HER2.